Merck Makes Investment in Moderna
Jan 14, 2015, 00:00 AM
by
Michael Croft
Forbes | Moderna Therapeutics has snagged another
$100m of financing, this time from Merck. A $50m cash up front
payment for messenger RNA technology along with a $50m equity
payment is a strong vote of confidence from the pharma in mRNA's
future.
January 14, 2015 | Moderna Therapeutics has snagged another $100m of financing, this time from Merck. A $50m cash up front payment for messenger RNA technology along with a $50m equity payment is a strong vote of confidence from the pharma in mRNA's future. Forbes


